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ABSTRACT
 
Evaluations on critical components of the Mobile Biological Isolation
 
System were performed. HEPA filter efficiency and suit integrity were found
 
to withstand repeated ethylene oxide (ETO) sterilizations. The minimum ETO
 
sterilization time required to inactivate all contaminant organisms was estab­
lished at four hours. Two days of aerating at 120°F was found to dissipate all
 
harmful ETO residuals from the suit. Donning and doffing procedures were
 
clarified and written specifically for isolation rooms.
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IITRODUCTION
 
The Mobile Biological Isolation System was originally designed for a
 
child with severe combined immune deficiency (SCID). Children born with SCID
 
only rarely survive to the age of one because of their impaired ability to
 
resist infection. -David, a child with SCID, hat now survived to the age of
 
eight in a sterile isolation room supplied with laminar filtered air.
 
Studies with leukemia patients confined to sterile isolation rooms, in
 
conjunction with antibiotics, antiseptics, and other microbial reducing
 
agents and techniques, have shown the value of this sterile environment for
 
the control of infections. Normally patients undergoing chemotherapy lose
 
resistance to infection in a manner similar to SCID's. However, significant
 
research and therapy is currently being conducted combining chemotherapy with
 
isolation room technology, since this has been found to reduce infection
 
rates.
 
One shortcoming of this treatment, however, is that it provides no
 
protection for patients when moved outside of the laminar airflow room. In
 
the case of pediatric patients such removal for medical reasons (i.e.,
 
X-rays) isoften necessary. In addition, it was considered of psychological
 
benefit for the patients to be able to leave the clean room enclosure for
 
play with other children and brief excursions. The Mobile Biological
 
Isolation System, by providing sterile filtered air and acting as a biological
 
barrier against contamination, would enable patients to engage in activities
 
outside of the laminar flow environment with a minimal risk of environmentally
 
induced infection. However, to ensure that this system with all its auxiliary
 
components and back-up subsystems would provide a safe environment, a variety
 
of tests were performed.
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OBJECTIVE
 
The objective of this effort was to evaluate the integrity of the Mobile
 
Biological Isolation System to ensure its proper functioning as a biological
 
barrier aqainst contamination. This effort involved a number of tasks:
 
TASK I: 	 Evaluation of HEPA filters efficiency after repeated ETO
 
sterilization.
 
TASK II: 	 Evaluation of suit integrity after reoeated ETO sterilization.
 
TASK III: 	 Determination of the minimum time required to sterilize the
 
suit.
 
TASK IV: 	 Determination of the minimum aeration time necessary to
 
dissipate harmful ETO residuals.
 
TASK V: 	 Recommended protocol for the determination of patient
 
microflora.
 
TASK VI: 	 Donning and doffing procedures.
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ABSTRACT OF EACH TASK
 
TASK I: EVALUATION OF HEPA FILTER EFFICIENCY AFTER REPEATED ETO STERILIZATION
 
The major component of the MBIS system is the HEPA filter utilized to
 
remove all viable organisms from contact with susceptible patients. Thus, the
 
efficiency and reliability of these filters is of paramount importance.
 
The objective of this task was to determine if repeated ethylene oxide
 
(ETO) sterilization induces filter degradation thereby decreasing filter
 
effectiveness. Twenty-five ETO sterilization cycles were scheduled, each
 
followed by a Freon TF aerosol test, since the DOP method might possibly con­
taminate the filters. After 18 ETO and Freon tests, no marked degradation or
 
loss of filter efficiency was noted. The additional seven tests were scheduled
 
for completion in conjunction with actual excursions of patients at Childrens
 
Hospital.
 
TASK II: EVALUATION OF SUIT INTEGRITY AFTER REPEATED ETO STERILIZATION
 
The objective of this task was to determine if repeated ETO sterilization
 
(up to 120°F) would produce leaks in the suit or otherwise degrade the suit
 
material, since the suit has numerous seams, some sewn and some glued, represen­
ting potential weak points. To test for this possibility leak tests were
 
performed according to JSC specifications. The snoop liquid (bubble) method
 
was found to be more practical than the halogen detection method. After each
 
ETO sterilization the snoon test showed no major leaks or suit degradation.
 
Several very minor leaks observed have been confirmed by JPL to be inher­
ent to the suit material and of no immediate concern. In any case, all future
 
excursions should be preceded by a leak test.
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TASK III: DETERMINATION OF THE MINIMUM TIME REQUIRED TO STERILIZE THE SUIT
 
Prior to each excursion the suit must be ETO sterilized to guarantee a
 
safe environment for each patient. The objective of this task was to determine
 
the minimum sterilization time, with assurance of sterility, necessary to kill
 
all viable organisms within the suit. This was accomplished by using Bacillus
 
subtilis var. niger spores as the indicator organism. Spore concentrations of
 
102, 10, 10 and 108 were placed within the suit in critical areas (boot,
 
glove, dome, groin and chest) and sterilized with ethylene oxide (ETO) for
 
various periods of tine. Initial results showed that three hours of sterili­
zation would inactivate all spores. However, in order to include a margin of
 
safety, an additional hour was added, establishing four hours for the sterili­
zation time. Five consecutive ETC runs consistently gave 100 percent kill,
 
confirming this standard.
 
TASK IV: DETERMINATION OF MINIMUM AERATION TINE IIECESSARY TO DISSIPATE
 
HARMFUL ETO RESIDUALS
 
Because ethylene oxide may be absorbed into the suit material and is toxic,
 
accurate determination of its concentration after sterilization was necessary.
 
In addition, ETO reacts with chloride ions and water to form several potentially
 
harmful residuals, ethylene chlorohydrin (ETCH) and ethylene glycol (ETG).
 
Federal standards have set the maximum permissible level for skin contact at
 
250 ppm for ETO, 250 ppm for ETCH and 1,000 ppm for ETG. However, good policy
 
would entail patient contact to be well below these limits accomplished by
 
aerating the suit at 120'F forced air flow for given periods of time.
 
The objective of this task was to determine the minimum aeration time
 
necessary to dissipate ETO and its residuals to well below harmful concentra­
tions. Concentrations were determined with gas chromatography according to
 
the method of Spitz and Heinberger after 0, 1, 2, 3 and 4 days of aeration.
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Immediately after sterilization, the ETO concentration was above the allowable
 
limits generating some concern, particularly for the glove, dome and seam.
 
Concentrations of ETCH and ETG were below the limits but present. Two days of
 
aeration reduced the ETO concentrations to'zero and for ETCH and ETG to
 
essentially trace quantities. Consequently two days of aeration was established
 
as the minimum aeration time for patient use.
 
TASK V: RECOMMENDED PROTOCOL FOR THE DETERMINATION OF PATIENT MICROFLORA
 
The objective of this task was to suppqrt Childrens Hospital of Los
 
Angeles (CHLA) in a joint effort to ensure system reliability of MBIS. On
 
August 7, 1978 the suit was delivered to CHLA. The JPL protocol for sampling
 
skin microflora was submitted to the Bacteriological Department. The plan
 
consists of pre- and post-bacteria sampling of both the patient and the suit.
 
TASK VI: DONNING AND DOFFING PROCEDURES
 
At this point in time four subjects have been processed. Donning and
 
doffing procedures have been clarified and rewritten to fit the particular
 
needs of CHLA isolation rooms. An excursion outside the isolation room to the
 
ground level lasted approximately one hour. Although the subject was comfort­
able and the excursion considered successful, the subject did not wish to
 
continue. Excursions outside the hospital have not been completed. However,
 
arrangements for such excursions will be made.
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TASK I
 
EVALUATION OF HEPA FILTER EFFICIENCY AND STABILITY
 
AFTER REPEATED ETO STERILIZATION
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INTRODUCTION
 
A major component of the ?IBIS system is the High Efficiency Particulate
 
Air (HEPA) filters utilized to remove all viable organisms from contact with
 
susceptible patients. HEPA filters are rated as 99.97 percent efficient in
 
removing 0.3 micron particles or larger which provides an effective barrier
 
to microbial contamination of filtered air. Since the PBIS system was
 
designed to permit maximum mobility while maintaining a sterile environment,
 
the air quality, efficiency, and durability of these filters is of paramount
 
importance to the system and patient.
 
One potential problem, however, is that the HEPA filters require ETO
 
sterilization at 120'F for up to four hours prior to each patient excursion.
 
Considering the numerous excursions and, hence, sterilizations necessary and
 
possible resulting decomposition of the filter media and adhesives binding the
 
media to the filter case, the probability of filter degradation and correspond­
ing loss of efficiency as a consequence has not been adequately determined.
 
OBJECTIVE
 
The objective of this task was to determine if repeated ethylene oxide
 
(ETO) sterilization would induce filter degradation thereby decreasing filter
 
efficiency and reliability.
 
MATERIALS 
Ethylene oxide gas sterilizer Laminar flow bench 
DOP (dioctylphthalate) Squirrel cage blower 
Freon-12 Iso-kinetic probe 
Sinclair-Phoenix Jr' 2000 Smoke generator 
Royco 225 particle counter Filter holder (plenum) 
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METHODS
 
Although a variety of methods were available for evaluating filter
 
efficiency, most of which involve challenging filters with chemicals, particu­
lates, or various microbes, several popular chemical techniques were considered;
 
DOP and Freon.
 
The DOP method, developed by the Army Chemical Corps, has gained wide
 
acceptance and is today extensively employed by filter manufacturers, theaero­
space industry, the Atomic Energy Commission, and many other users of HEPA
 
clean systems. This method utilized a vaporized organic liquid referred to as
 
DOP (dioctylphthalate), which is a plasticizer used by the chemical industry to
 
impart flexibility to various products. For some applications the DOP method
 
conveys significant advantages but it does bleed through the HEPA filters as
 
well as contributing organic material to an environment specifically requiring
 
low organic contamination.
 
For environments requiring low organic levels, such as with the IBIS system,
 
an alternative leak test-method was available; the Freon-121 method developed
 
by A. R. Walters of the Northrop Corporation and J. C. Hurgeton of Bio-Netics
 
Corporation (Reference 1). This method challenges filters with Freon-12 and
 
the filtered air is monitored with a Royco 225 counter. It is fast, inexpen­
sive, and reported nearly as accurate as DOP. Also, no potential harmful
 
residuals remain to contaminate the filtered air, as Freon readily evaporates
 
and has no apparent effect on the filter media. For these reasons Freon-12 was
 
the method of choice.
 
PROCEDURE
 
A series of Freon leak tests on a single HEPA filter following each ETO
 
sterilization was the test plan; specifically, eighteen consecutive tests were
 
ITrademark of E.I. duPont de Nemours and Co., 
Inc.
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performed. However, prior to the initiation of this schedule, a comparison
 
test of DOP and Freon methods were evaluated.
 
The set-up for comparison involved the following. A HEPA filter was
 
positioned in a filter holder attached to a squirrel cage blower, smoke gener­
ator, and DOP source, in that order. A Sinclair-Phoenix JM 2900 particle
 
counter was calibrated according to manufacturer specifications. DOP was
 
volatilized in the smoke generator and forced through the filter with positive
 
pressure by the blower. In a similar manner Freon-12 was introduced to the
 
filter. Both chemicals were monitored by hand with an iso-kinetic probe
 
attached to the Sinclair-Phoenix. First, the central portion of the filter
 
was scanned, then the sides adhering the filter media to the filter case were
 
monitored and the results recorded.
 
The results (Figures 1 and 2) showed a close comparison between the two
 
methods, although DOP was slightly more sensitive, and indicated that DOP and
 
Freon can be interchanged according to preference. M4oreover both methods
 
demonstrated a high degree of filtering efficiency for the filter tested.
 
For the eighteen consecutive Freon determinations, a separate apparatus
 
(Figure 3) was employed. All Freon challenges were performed in a laminar
 
flow bench. Freon-12, under pressure, was forced into the blower which
 
further volatilized the Freon. The blower also forced the Freon through the
 
filter with positive pressure.
 
In this testing mode, a single HEPA filter was ETO autoclaved at 120°F
 
for four hours and immediately tested for efficiency with the above method­
ology. This procedure was repeated for eighteen consecutive runs.
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RESULTS
 
The results of the eighteen Freon tests (Table 1) showed all readings
 
were well below the Federal Standard of 0.01%. Furthermore, there appeared
 
to be an increase infilter efficiency during the testing program. This is
 
a known phenomenon of HEPA filters; they tend to increase in filter efficiency
 
due to particulate matter blocking the larger pores of the filter media,
 
thereby allowing progressively smaller pores for filtration.
 
CONCLUSION
 
After eighteen repeated ethylene oxide sterilizations at 120F, Freon
 
tests on the filtered air indicated no marked degradation or loss of filter
 
efficiency, but in fact, showed a slight improvement.
 
REFERENCES
 
1. 	Walters, A. R. and .. C. Hurgeton, HEPA Filter Leak Testing Using Freon
 
TF Aerosol, prepared by Northrop Corporation, Electronics Division,
 
Precision Products Department, Norwood, Massachussetts, and by Bio-Netics
 
Corporation, Langley, Virginia.
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FIGURE 1. 	DDP Leak Test on HEPA Filter showing percent
 
of upstream concentration through filter.
 
Tolerance limit is 0.01 percent.
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Figure 2. Freon-12 Leak Test on HEPA Filter showing 
percent of upstream concentration through 
filter. Tolerance limit is 0.01 percent. 
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TABLE 1. Results of eighteen consecutive Freon tests, each after a ETO 
Sterilization. 
TASK II
 
EVALUATION OF SUIT INTEGRITY AFTER REPEATED
 
ETO STERILIZATION AT 120°F
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INTRODUCTION
 
The Mobile Biological Isolation System was designed to withstand tempera­
tures as high as 130'F, but higher temperatures or prolonged exposures could
 
possibly damage the suit. The upper limit of temperature resistance of the
 
MBIS suit is primarily determined by the Neoprene adhesives (Reference 1) used
 
in the construction of the dome, boots, gloves and seams. Since those high
 
temperatures are known to degrade adhesive bondings, this may reduce the per­
formance of the suit to act as a biological barrier by causing leaks.
 
However, high temperatures could not be avoided because (ETO) steriliza­
tion uses moderate heat over several hours, which could conceivably cause
 
degradation of the suit. To introduce a margin of safety against possible
 
temperature variations of the autoclave, the sterilizing temperature was
 
purposely reduced from 130 to 120°F. Moreover, the effects of repeated
 
sterilizations even at this lower temperature have not been adequately deter­
mined and remain for analysis.
 
OBJECTIVE
 
The objective of this task was to determine if repeated ETO sterilization
 
at 120°F degrades the adhesives binding the suit or suit materials resulting
 
in major or minor leakage.
 
MATERIALS
 
6-year-old suit Halogen leak detector (GE Type H-l0) 
9-year-old suit Liquid snoop 
Blower (squirrel cage) Duct tape 
Tygon tubing Freon-12
 
METHOD
 
The fundamental methodology for assaying possible suit degradation was
 
the performance of leak tests on the suit after each sterilization cycle. Two
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methods were employed for this purpose. The first method utilized Freon-12 
and a Halogen Leak Detector. The second method enployed a liquid leak 
detector (snoon) which bul-bles when in contact with a leak. Both methods were 
used after each of 5 sterilization cycles on both the 6-year-old and 9-year­
old suits.
 
To conduct these tests the exhaust ports on the two MBIS suits were
 
sealed with duct tape. The squirrel cage blower was connected to the inlet
 
hose of the suit dome and turned on, producing a differential pressure in the
 
suit of 0.15 psi. The closed ports were then tested with snoop liquid leak
 
detector to reveal any possible leaks around the duct tape. No leaks were
 
observed.
 
In this testing mode (Figure 4), Freon-12 was introduced into the system
 
by way of the blower and hose assembly. The outer surface of the suit was
 
then scanned with a halogen leak detector to determine the presence or absence
 
of Freon-12 and all leaks were plotted per attached drawing.
 
In a similar manner the snoop leak detector was used to locate bypasses
 
of the suit, except Freon-12 was not used, The snoop liquid was brushed over
 
the entire surface of the suit and all bubbles indicating leaks were recorded­
per attached drawing.
 
RESULTS
 
Of the two methods used, the snoop leak detector proved to be the most
 
rapid and accurate. The Freon method utilizing a Halogen Leak Detector
 
worked well but was more difficult to differentiate gases other than Freon-12
 
inteferring with the instrument.
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The tests on the 6-year-old suit (Figures 5 and 6) indicated only one
 
very slightly detectable leak on the right wrist (Finure 5). This leak was
 
observed in the first test and did not increase due to repeated ETO sterili­
zations. All other areas of the 6-year-old suit were, by both methods used,
 
completely devoid of leaks during the entire testing series.
 
The 9-year-old suit (Figures 7 and 8) similarly revealed a minor leak in
 
the chest area (Figure 7), which also did not increase in severity with repeated
 
sterilizations. Even after 5 ETO sterilization cycles no other leaks were
 
observed.
 
CONCLUSION
 
The two minor leaks observed did not increase or further degrade due to
 
sterilization at 1200F. Furthermore, JSC has confirmed their presence and
 
also confirmed that they are of no immediate concern but inherent properties
 
of the suit material and construction.
 
More importantly, after repeated sterilization no additional leaks were
 
produced at these operatina temperatures.
 
These tests demonstrate the ability of the MBIS suit to withstand ETO
 
sterilization temperatures of 120°F and not degrade. Further, even very
 
slight leaks present no problem to the suit functioning as a biological
 
barrier, as microbes cannot enter the sterile environment of the suit due to
 
positive pressure from the suit toward the exterior.
 
Consequently it was concluded that repeated ETn sterilization at 120'F
 
does not detrimentally affect or degrade the integrity of the MBIS suit.
 
However, as a safety precaution, a leak test should be performed after each
 
succeeding sterilization and excursion.
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FIGURE 6. Back of 6-year-old suit showing no leaks. 
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FI'GURE 7. Front of 9-year-old suit'showing a minor leak in chest area. 
23
 
FIGURE 8. Back of 9-year-old suit showing no leaks. 
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TASK III
 
DETERMINATION OF THE MINIMUM 
TIME REQUIRED FOR
 
ETO STERILIZATION OF THE SUIT
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INTRODUCTION
 
Because of patient sensitivity to microbes it is absolutely essential that
 
the suit be sterilized to insure that all viable orqanisms are effectively
 
inactivated. The importance of complete sterilization prior to patient use
 
cannot be over emphasized.
 
However, heat sterilization was not possible with the Mobile Biological
 
Isolation Suit because of plastic degradation at high temperatures. Consequent­
ly, the most feasible method of sterilization at lower temperatures was the
 
utilization of ethylene oxide (ETO) gas, which has been shown to be lethal
 
even to the most resistant of spores, and yet not destructive to many heat
 
sensitive materials.
 
Significantly there are two important limitations with ETO sterilization.
 
Firstly, even ETO sterilization requires a moderate temperature, usually at
 
130'F, and this temperature, although not harmful to plastics, may possibly
 
be detrimental to adhesives used in construction of the suit. This may be
 
particularly significant if the suit is submitted to numerous ETO cycles. To
 
compensate for this factor, the ETO operational temperatures were lowered from
 
130°F to 1200F,which, however, will increase sterilization time.
 
Secondly, ETO sterilization is a function of contact time. 11ith heat
 
sterilization, contact time is not as important due to the fact that all
 
elements within the autoclave quickly equilibrate to the high operating temp­
erature. With gas sterilization, however, contact tine is dependent upon
 
diffusion of ETO to all crevices and pockets of the material to be sterilized.
 
This is precisely the problem of this task: how long should the contact
 
or sterilization time be for complete sterilization of the suit, considering
 
that when the suit is folded and wrapped in surgical cloth gas, diffusion into
 
all areas will be greatly reduced?
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OBJECTIVE
 
The objective of this task is to determine the optimum ETO sterilization
 
time required to guarantee complete inactivation of all organisms in all
 
positions of the MBIS suit.
 
MATERIALS
 
Ethylene Oxide Autoclave
 
B.S.N. spore strips (102, 104, 105, 106 and 108)
 
Tryticase Soy Broth Tubes (lOml)
 
Incubator (37°C)
 
Surgical Muslin Cloth
 
METHODS
 
To test for complete ETO inactivation a rather resistant and hardy spore,
 
Bacillus subtilis var. ne (B.S.N.), was selected as the test organism.
 
The spores were obtained as prepared strips with the following concentrations;
 
102, 104, 106 and 108. These viable B.S.NI. spore strips were placed in
 
critical areas of the suit (Figure 9): the dome, boot, glove, chest and
 
groin. Additional B.S.. spore strips (105)were placed in the filter hose
 
and filter. Corresponding spore strips not exposed to ETO were used as
 
controls.
 
The suit was then folded, double wrapped in surgical muslin cloth, and
 
placed in ethylene oxide (ETO) autoclave for various periods of time: 2, 3,
 
and 4 hours. All ETO temperature and pressure data were monitored on charts
 
to assure that the temperature never exceeded 120'F and stored for future
 
reference (see Figures 10 through 16).
 
After sterilization the spore strips were aseptically removed from the
 
various suit positions, placed in sterile trypticase soy broth and incubated
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at 370C. Incubation lasted from 3 to 7 days before the results were scored.
 
Growth, denoted by cloudy broth, was indicative by insufficient exposure
 
and sterilization of ETO gas, and was hence, scored positive (see Table 2).
 
No growth, denoted by clear broth, indicated sufficient ETO exposure and
 
complete inactivation of all spores and was thus scored negative.
 
RESULTS
 
At no time did temperatures exceed 120'F (Figures 10 through 16).
 
A two-hour ETO cycle (Table 2) showed incomolete inactivation of the
 
spores, particularly for the 106 and 108 spore strips within the boot and
 
glove areas. Apparently these appendages are the most critical areas of the
 
suit for gas sterilization. ETO may penetrate into these areas more slowly
 
than 2 hours and also the thicker rubber of the boots and gloves may absorb
 
ETO, thereby decreasing the ETO concentration and its bactericidal effective­
ness. The minimum sterilization time to kill all viable B.S.I. spores was
 
three hours (Table 2).
 
Although a three-hour cycle appeared sufficient to inactivate all B.S.N.
 
spores, at least in the single test, an additional hour would ensure complete
 
sterilization and provide a margin of safety. Consequently five consecutive
 
four-hour tests were performed, resulting in 100 percent mortality for all
 
B.S.N. spores in all suit positions (Table 2).
 
CONCLUSION
 
These tests confirm that a four-hour ETO sterilization time is sufficient
 
to guarantee complete inactivation of all organisms when tested with B.S,.N.
 
spores.
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POSITION 
CONCENTRAION 
OFS-O S 
2 hr. 
n 
3 hr. 
run 
I st 
hr. 
4 
run 
2 nd 4 
hr run 
3 rd 4 
hr. ru 
4 th 4 
run 
5 th h 
hr. run 
Dome 102 
106 
-
- -
Boot 
108 
102 
+ 
Glove 
106 
108 
102 
+ 
+ 
-
Chest 
Ch0tto 
106 
108 
102 
106 
+ 
+ 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
108 - - - - - - -
Groin 10 2 
106 
108 
-
-
- - - - -
SUIT 
CONTROL 
Hose 
HOSE CONTROL 
Filter 
102 
10106 
108 
o5 lo5 
to 5 
105 105 
+ 
++ 
+ 
+ 
+ 
++ 
+ 
+ 
+ 
++ 
+ 
+ 
++ 
+ 
+ 
+ 
++ 
+ 
+ 
+ 
++ 
+ 
+ 
+ 
++­
+ 
+ 
FITER CONTROL1O 5 + + + + 
PERCENT KIM 4o% lO% ioo% ioo% 100% oo% 100% 
(-)(+) negative means no growth. positive means growth confirmed. 
TABLE 2, 	Results of ETO sterilization of suit with B.S.N. spores as the
 
indicator organisms.
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FIGURE 9. Position of B.S.N. Spores
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FIGURE 10. Two-hour ETO sterilization chart showing temperature less
 
than 120°F.
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FIGURE 12. 	 First four-hour ETO sterilization chart showing temperature
 
less than 120'F.
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FIGURE 13. 	 Second four-hour ETO sterilization chart showing temperature
 
less than 120°F.
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FIGURE 14. Third four-hour ETC sterilization chart showing temperature

less than 120nF. 
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4 M 
FIGURE 15, 	 Fourth four-hour ETO sterilization chart showing temperature
 
less than 120°F.
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FIGURE 16. 	 Fifth four-hour ETO sterilization chart showing temperature
 
less than 1200F.
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TASK IV 
DETERD NATION OF MINIMUM AERATION TIME NECESSARY
 
TO DISSIPATE HARMFUL ETO RESIDUALS
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INTRODUCTION
 
Ethylene oxide (ETO) sterilization of the MBIS suit produces harmful
 
residuals differentially absorbed in the various suit components. Because
 
ETO is toxic, even at low concentrations, accurate determinations of the
 
residual suit concentrations were absolutely mandatory before patient use.
 
Inaddition ethylene oxide can react with chloride ions present in the
 
suit to form ethylene chlorohydrine (ETCH) and with water to form ethylene
 
glycol (ETG), both of which are also toxic.
 
Since this possible toxicity to patients coming in contact with a steril­
ized suit depends on the concentration levels, gas chromatography (Reference 2)
 
was used for the low-level residual determinations. Permissible safe levels
 
established by the FDA (Reference 1) for devices contacting skin are:
 
Ethylene Oxide 250 ppm 
Ethylene Chlorohydrin 250 ppm 
Ethylene Glycol 1,000 ppm 
In anticipation that these toxic residuals induced by ETO sterilization
 
may exceed maximum exposure limits, aerating the suit for various periods of
 
time 	was expected to dissipate these residuals from the suit. Further, dis­
sipation could be accelerated by a forced warm air flow, shortening the
 
minimum aeration time.
 
OBJECTIVE
 
The objective of this task was two-fold:
 
1. 	To determine the initial concentrations of ETO, ETCH and ETG in the
 
MBIS suit immediately after sterilization.
 
2. 	To determine the minimum aeration time reenred to dissipate these
 
residuals from the suit to well below FDA safety limits.
 
39
 
EQUIPMENT AND MATERIALS
 
The following equipment and chemicals were used for the gas chroma­
tographic determination of ethylene oxide, ethylene chlorohydrin, and
 
ethylene glycol levels:
 
Varian Gas Chromatography #1440
 
Chromosorb 101 column for Ethylene Chlorohydrin and Glycol
 
Chromosorb 102 column for Ethylene Oxide
 
Autolab Minigrator (Spectra-Physics)
 
Hewlett-Packard Chart Recorder 7127A
 
Bubble Meter
 
Ethylene Oxide
 
Ethylene Chlorethanol (Eastman Kodak 131-250)
 
Ethylene Glycol (Eastman Kodak 133)
 
MBIS suit samples
 
Hamilton 1 i1syringes #7001
 
Silicone Septa W-9 (Applied Science #15432)
 
30 ml hypo-vials (Pierce Chemical #12944)
 
Silicone Rubber Septa (Pierce Chemical #13237)
 
Aluminum caps and cap crincher
 
METHODS
 
Since the measurement of the minute concentrations of ETO, ETCH and
 
ETG absorbed in the suit material required data in the nanogram range,
 
gas chromatography techniques were utilized as the most appropriate and
 
accurate.
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The three gases used for chromatogram determinations were regulated with
 
the aid of a bubble meter. Helium was the carrier gas with a flow rate of
 
30 ml/mln., while air was set at 300 ml/mn. and hydrogen at 30 ml/min.
 
Temperatures were also important, as slight variations produced larger
 
differences in the measured results. The detector terperature for all resid­
uals was adjusted to 200'C. For the analysis of ethylene oxide, the oven
 
temperature was 100'C and the injector was 1200C. For ethylene chlorohydrin
 
and ethylene glycol deterninations, the oven was 1600C and the injector was
 
1950C.
 
The chromatography columns were conditioned prior to use. Chromosorb 102,
 
used for the detection of ethylene oxide, was conditinned for 1 day in a 200C
 
oven with a continuous helium flow of 30 ml/min. After 24 hours 1 p1 of ace­
tone was injected into the column every 15 minutes for approximately 3 hours.
 
Chromosorb 101, used for ethylene chlorohydrin and ethylene glycol, was
 
conditioned as above except that the 1 p1 injections consisted of distilled
 
water.
 
For instrument calibration, standard solutions of the three residualsin
 
the nanogram range were prepared. Several drops of ethylene oxide and
 
ethylene chlorohydrin were separately weighed in clean beakers and the volumes
 
were adjusted to 1 liter. Serial dilutions of these stock solutions were
 
then made from 120 ng/pl down to 12 ng/pl ethylene oxide and from 102 ng/pl
 
to 5.25 ng/pl ethylene chlorohydrin (see Table 3).
 
Because ethylene glycol is an alcohol not blending itself to serial
 
dilutions, a different method was used for the ETC standards. Six concentrations
 
were individually weighed using a lamda micropipette. Each succeeding
 
concentration was approximately doubled, giving ethylene glycol standards
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from 156 to 30 ng/pl (see Table 3).
 
One jIl of these standards was injected into the appropriate column and
 
the corresponding data was later used to construct a calibration curve,
 
relating gas chromatography readings with the concentration of residuals in
 
nanograms.
 
Two instruments were used to monitor gas chromatography outputs:
 
(1)a chart recorder, and (2) a computing integrator (Spectra-Physics Hini­
grator). A comparison of these two methods revealed the most accurate and
 
also the potential variations inherent within both systems.
 
A series of 1 p1 injections with a standard 50 ng/yl solution of ethylene
 
chlorohydrin was used. Both the chart recorder and the minigrator were simul­
taneously monitored. The peak heights of the chart recorder were later
 
measured in centimeters. The area under the curve was automatically calculated
 
by the minigrator which had the following programmed parameters; PW at 15,
 
SS at 20, TP at 20 and T1 at 100.
 
Test results verified narrow confidence intervals for both methods.
 
The peak heights of the chart recorder were within ±6 percent while the mini­
grator units were within 13 percent, which are the expected variations for
 
future chromatography analyses. In addition these statistics include vari­
ations of the injector syringe, variation of the various temperatures and gas
 
flow parameters, and human variations.
 
Because the minigrator is more accurate, easier to use, and quicker,
 
itwas the method of choice for all sample analyses.
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PROCEDURE
 
The determination of residuals within the suit after sterilization
 
required: autoclaving suit samples, suspending the samples in solution,
 
injecting 1 yl of solution into the appropriate column, recording the results
 
in nanograms, and calculating residual concentrations in parts per million
 
(ppm).
 
Uniform samples of the five suit materials, boot, glove, dome, suit and
 
seam were cut with a cork borer. Twenty representatives of each material
 
were weighed giving the following data:
 
Boot 0.0791 + 0.016 grams 
Glove 0.0651 ± 0.0025 grams 
Dome 0.0938 + 0.0009 grams 
Seam 0.2439 ± 0.0046 grams 
Suit 0.0798 + 0.0026 grams 
Statistical analysis showed consistant weights with narrow confidence
 
intervals having a maximum variation of ±3.8 percent. This uniformity justi­
fied allowing the above averages to be used in later tests for calculating
 
ppm without reweighing each sample individually.
 
All suit materials were placed in their corresponding suit locations,
 
for example, the dome sample was positioned in the dome, etc., wrapped in
 
surgical cloth, and ETO autoclaved for 4 hours. One sample of each material
 
was removed and immediately analyzed for ETO, ETCH and ETG concentrations.
 
The remaining samples were left in the suit which stas placed in a 120°F
 
forced air aerator.
 
Each day thereafter for 4 days, samples were removed from the suit and
 
analyzed. One series of samples was placed in 5 ml of acetone and analyzed
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for ethylene oxide. A second series was placed in 5 ml of distilled water
 
and allowed to soak for 24 hours before ethylene chlorohydrin and ethylene
 
glycol determinations were made.
 
Analysis consisted of injecting 1 I of sample solution into the gas
 
chromatography unit. The resulting minigrator readings were recorded and
 
later converted into ng/vl usinq the prepared calibration curves. Parts
 
per million (ppm) were calculated from the following formula:
 
ppm = 0.5 x ng/vl
 
average weight of sample (g)
 
RESULTS
 
The initial ethylene oxide concentrations without any aeration were
 
higher than the maximum FDA limits of 250 ppm (Table 4), particularly for
 
the glove, dome and seam. This justified aeration to dissipate this toxic
 
gas. After aerating for 1 day with a forced air flow, the ethylene oxide
 
levels were reduced to minor concentrations. After 2 days all suit samples
 
were zero (Table 4).
 
With no aeration, ethylene chlorohydrin was well below the limit of 250
 
ppm, the highest concentration was 84 ppm in the seam. Aerating reduced
 
these low concentrations. However, all ethylene chlorohydrin was not dis­
sipated until after 4 days (Table 4).
 
Ethylene glycol was well below the maximum concentrations of 1,000 ppm
 
in all suit materials (Table 4). Most readings were below the lowest
 
detectable levels, between less than 45 to less than 169 ppm.
 
Although non-aerated ethylene oxide concentrations were higher than
 
ethylene chlorohydrin and ethylene glycol, it is dissipated more quickly
 
from the suit materials probably because it is a gas, whereas ethylene
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chlorohydrin and ethylene glycol are liquids at room temperature and slower
 
to dissipate.
 
CONCLUSION
 
The objective of this task was to determine the minimum aeration time
 
necessary to dissipate ethylene oxide and its residuals to well below harm­
ful concentrations. Concentrations were determined by gas chromatography
 
after 0, 1, 2, 3 and 4 days of aeration. Immediately after sterilization,
 
ethylene oxide concentrations were above the allowable FDA limits, generating
 
some concern, particularly for the glove, dome and seams. Concentrations
 
of ethylene chlorohydrin and ethylene glycol were below the FDA limits but
 
present. Two days of aeration reduced the ethylene oxide concentrations to
 
zero and for ethylene chlorohydrin and ethylene glycol to essentially trace
 
quantities. Consequently, two days of aeration was established as the
 
minimum aeration time for patient use.
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ETHYLENE OXIDE STANDARDS
 
n_-/Jl Minigrator Readings

-

120 10,481 
60 5,146 
36 3,083 
24 1,991 
12 1,059 
ETHYLENE CHLOROHYDRIN STANDARDS 
Minigrator Readings 
ngiL/ #1 #2 #3 Average 
105. 3,354 3,597 3,857 3,603 
79 2,881 2,628 2,775 2,761 
52.5 1,850 2,641 1,945 1,812 
26 906 853 885 881 
15.75 721 581 660 654 
10.5 305 268 277 283 
5.25 91 58 88 79 
ETHYLENE GLYCOL STANDARDS 
Minigrator Readings 
_____ #1 #2 #3 #4 Average 
156 2,715 2,349 2,340 3,004 2,602 
90 1,081 2,163 1,170 1,283 1,175 
63 853 762 800 654 763 
55 603 587 612 541 587 
48 438 256 549 421 416 
30 179 190 200 222 198 
TABLE 3. CALIBRATION CURVE RELATING MINIGRATOR UNITS TO ng/yl
 
46
 
ETHYLENE OXIDE IN PPM (Limit is 250 ppm)
 
Aeration time in days
 
0 1 2 3 4
 
BOOT 167 13 0 0 0
 
GLOVE 438 0 0 0 0
 
DOME 560 16 0 0 0
 
SEAM 271 0 0 0 0
 
SUIT 119 0 0 0 0
 
ETHYLENE CHLOROHYDRIN IN PPM (Limit is 250 ppm)
 
Aeration time in days
 
0 1 2 3 4
 
BOOT <19 0 0 0 0
 
GLOVE 62 38 35 <23 0
 
DOME 0 0 0 0 0
 
SEAM 84 27 18 15 0
 
SUIT 38 <19 <19 <19 0
 
ETHYLENE GLYCOL IN PPM (Limit is 5,000 ppm)
 
Aeration time in days
 
0 1 2 3 4 
BOOT <139 <139 152 170 0
 
GLOVE <169 0 <169 0 23
 
DOME <117 <117 0 0 0
 
SEAM < 45 0 < 45 0 <45
 
SUIT <138 <138 <138 0 0
 
TABLE 4. RESIDUAL CONCENTRATIONS OF BOOT, GLOVE, DOME, SUIT and SEAM
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TASK V
 
RECOMMENDED PROTOCOL FOR THE SAIPLING OF SKIN MICROFLORA
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The following protocol is recommended for analysis of microflora before
 
and after each patient excursion. A total of nine locations should be sampled.
 
1. 	Neck - Ilicroflora sarnles from the back of the neck should be taken with 
sterile cotton swabs moistened in trypticase soy broth (TSB). Ilashing 
should be made of a A x 5 cm area by rubbing thoroughly. After sampling, 
the swab should be inserted into a test tube containing 5 ml of sterile 
TSB and sonicated for 5 minutes. Subsequently the solution should be 
I
diluted to 10O, I0, 1o2, 103 and 104 with TS5 and plated on nutrient agar.
 
After three day's of incubation at 370C, plate counts should be made and
 
converted to organisms ner cm2.
 
2. 	Hair - Microflora samnles from hair in the region behind the head should 
be taken with sterile cotton swabs moistened in trypticase soy broth (TSB). 
Washing should be made of approximately a 4 x 5 ci area by rubbing portions 
of hair. After sampling, the swab should be inserted into a test tube 
containing 5 ml of sterile TSB and sonicated for 5 minutes. Subsequently 
the solution should be diluted to 10O, 101, 102, 103 and 104 with TSB 
and plated on nutrient agar. After three days of incubation at 37°C, 
2
plate counts should be made and converted to organisms per cm .
 
3. 	Axilla - Microflora samples from the armpits (axilla) should be taken with
 
sterile cotton swabs moistened in TSB by rubbing both armpits thoroughly.
 
After sampling, the swabs should be inserted into a test tube containing
 
5 ml of sterile TSD and sonicated for 5 minutes. Subsequently the
 
solutions should be diluted to 100, 101, 102, 103 and 104 with TSB and
 
plated on nutrient anar. After three days of incubation at 370C, plate
 
counts should be made and converted to organisms per armpit.
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4. 	Groin - Microflora samples from the region of the groin should be taken
 
with sterile cotton swabs moistened in trypticase soy broth (TSB).
 
11ashing should be conducted by thoroughly rubbing the indicated area of
 
skin. After samplinn, the swab should be inserted into a test tube
 
containing 5 ml of sterile TSB and sonicated for 5 minutes. Subsequently
 
the solution should be diluted to 100, 101, 102, 103 and 104 with TSB
 
and plated on nutrient anar. After three days of incubation at 370G,
 
plate counts should be made.
 
5. 	Throat Swab - fricroflora samples from the tonsil area of the throat
 
should be taken with a dry, sterile cotton swab. Sample collection is
 
accomplished by rubbing the swab on the surface of the tonsils. After
 
sampling, the swab is inserted into a sterile test tube containing 5 ml
 
of sterile TSB and sonicated for 5 minutes. This solution should
 
subsequently be diluted to 100, 101, 102, 10, 104, 105 and 106 in TSB
 
and 4 ml plated on the surface of nutrient media. Following this, one
 
ml of the remaining sample is placed into 5 ml of nutrient broth and
 
incubated at 370C for 6 hours. After incubation, the sample is
 
streaked onto blood anar plate to isolate Beta homolytic streptococci.
 
6. 	Gargle Samples - ificroflora samples should be taLen from the mouth and 
oral cavity by washing once with 10 ml of PBS solution. Washing is 
conducted by garglino in the recesses of the mouth and the region of the 
pharynx for 30 seconds. After this the liquirl is collected and divided 
2 lo
equally. One part will subsequently be diluted to 100 , 101I 102, 103,
 
104 and 105 and plated on the surface of nutrient media. The remaining
 
portion of the original sample should be centrifuged at 3,000 rpm for 15
 
minutes. lithdraw the supernatant and plate approximately 1.5 ml of the
 
residual on nutrient media.
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7. 	Auditory Canals - Nicroflora are sampled from both ear channels by
 
rubbing with a sterile cotton swab moistened in PBS. After sampling, the
 
swabs should be inserted into a test tube containing 5 ml of sterile TSB
 
and sonicated for 5 minutes. Subsequently the solutions should be
 
0 	 1 2 4diluted to 10 , 10 , 10 , 103 and 10 with PBS and plated on nutrient 
agar. After three days of incubation at 37%, plate counts should be
 
made.
 
8. 	Nostrils - Microflora from the recess of the nose should be taken with
 
the aid of a dry sterile cotton swab. During this procedure, the
 
mucous should be taken from the forward and middle part of both nasal
 
channels. After sampling, the swab should be inserted into a test tube
 
containing 5 ml of sterile TSB and sonicated for 5 minutes. Subsequently
 
the solution should be diluted to 100, 101, 102, 103 and 104 with TSB
 
and plated on nutirent agar.
 
9. 	Toe Webs - Microbial samples from between the toes of both feet should be 
collected by rubbing between the toes with a sterile cotton swab moistened 
in TSB. After sampling, the swab should be inserted into a test tube 
containing 5 ml of sterile TSB and sonicated for 5 minutes. Subsequently, 
the solution should be diluted to 100, 101, 102, 103 and 104 with TSB 
and plated on nutrient agar. 
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TASK VI 
DONNING AND DOFFING PROCEDURES
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The following donnina'and doffing procedures i'ere developed at Childrens
 
Hospital at Los Angeles by rlrs. R. Woldan of CHLA, Bill'Carmine of JSC and
 
by Bionetics personnel. Children of similar age and heights as chemotherapy
 
patients were used in the development of these procedures.
 
SUIT 	DONNING
 
Three attendants should directly assist in both donning and doffing. One
 
nurse should "suit up" and enter the PT room. The other two attendants
 
should assist the patient outside the red lines near the door. Care and
 
caution should be maintained at all times to minimize any contamination.
 
a. 	Verify that subject is prepared and positioned to don suit.
 
b. 	Unzip protective flap.
 
c. 	Unsnap the 3 retention snaps and secure the sleeves to prevent
 
rolling.
 
d. 	Switch BLSS SI from norm to emer.
 
e. 	Unroll sleeves and release velcro fasteners.
 
f. 	Place boots on the floor or low bench and hold top of suit up
 
from entry sleeve at shoulders.
 
g. 	Subject should place feet in legs of suit and stand up into boots.
 
h. 	Have subject bend forward at the waist and enter the upper torso
 
with the head and shoulders.
 
i. 	Have subject stand and pull suit onto the body.
 
j. 	Have subject don one arm at a time.
 
k. 	Fit the subjects fingers into the gloves.
 
1. 	Fasten velcro fasteners on entry sleeve.
 
m. 	Switch BLSS SI to norm.
 
n. 	Fold edges of entry sleeve in and secure velcro.
 
o. 	Begin rolling entry sleeve as tightly as possible slowly toward
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the subjects torso while suit air is expelled from the leg vents.
 
p. Secure the 3 restraint straps. 
q. Close zipper on protective flap. 
r. Assist subject in exiting the room. Assist subject into cover 
garment ­ legs first, then arms. 
s. 	 Fasten short air hose tether straps to shoulders of suit under
 
cover garment.
 
t. 	Fasten cover garment straps across torso back - fasten velcro at
 
back of neck and ankles,
 
u. 	Run long air hose tether straps over shoulders, under arms and
 
fasten.
 
v. 	Verify differential pressure gauge is indicating between 0.15 and
 
0.30 	psi.
 
SUIT 	DOFFING
 
a. 	A low bench should be positioned inside of PT room near the doorway
 
and a sterile blanket placed on top. The bench should be extended
 
slightly beyond the doorway but not beyond the outside red lines.
 
b. 	First attendant sets up sterile basin with Biomet bacteriocide on
 
a sterile field just outside the room.
 
c. 	Have the subject stand with back to doorway of room, just outside
 
the red line.
 
d. 	Second attendant dons sterile gloves, and using sterile washcloth,
 
wipes the entire protective flap and zipper area with Biomet.
 
e. 	Second attendant'unzips suit back and unsnaps retention straps.
 
Unroll the sleeve and hold top and bottom of sleeve taut. 
f. 	First attendant dons sterile gloves and wipes outside of entire
 
sleeve with Biomet.
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g. Nurse inside room assists subject through open sleeve and attendants 
outside assist by holding suit while subject is doffing. 
h. Have subject remove arms from suit, one at a time. 
i. have subject bend at waist, remove head from helmet, and sit back 
on end of bench, leaning back to remove upper torso from suit. 
j. Attendant will pull suit and blanket covering bench from doorway 
area. 
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